Sumner A E, Bergman R N, Vega G L, Genovese D J, Cochran C S, Pacak K, Watanabe R M, Boston R C
NIDDK, National Institutes of Health, Bethesda, MD 20892, USA.
Metabolism. 2004 Sep;53(9):1202-7. doi: 10.1016/j.metabol.2004.03.020.
As small increments in insulin concentration profoundly affect lipolysis, our goal was to describe the free fatty acid (FFA) profile during the frequently sampled intravenous glucose tolerance test (FSIGT) and determine if both endogenous and exogenous insulin influenced the FFA profile. Thirteen subjects had both a glucose-only (GO-FSIGT) and insulin-modified FSIGT (IM-FSIGT). Both protocols were of 6 hours duration. At baseline an intravenous glucose bolus (0.3 g/kg) was given. In the IM-FSIGT, insulin was infused from 20 to 25 minutes (4 mU/kg. min). Six additional subjects had both an IM-FSIGT and a normal saline study (NS-Study). For the NS-Study, normal saline solution was infused instead of glucose and insulin. Fasting glucose, insulin, FFA and epinephrine concentrations were similar for all tests. Endogenous insulin peaked at 4 +/- 1 minute in both FSIGTs. The mean calculated peak time of exogenous insulin in the IM-FSIGT was 26 +/- 1 minute. Glucose concentrations were lower and epinephrine concentrations higher in the IM-FSIGT versus GO-FSIGT. During the FSIGTs, the FFA time course revealed four distinct phases, which did not differ between protocols. In phase I (0 to 11 minutes), FFA levels remained near basal (491 +/- 183 micromol/L); in phase II (11 to 79 minutes), FFA levels declined achieving a nadir of 139 +/- 63 micromol/L; in phase III (79 to 188 minutes), FFA levels rose linearly and reattained basal levels; and in phase IV (188 to 360 minutes), FFA levels rose above basal and plateaued at 732 +/- 214 micromol/L (P <.001). In the NS-Study, FFA levels remained near baseline (388 +/- 118 mEq/L) until 180 minutes and then trended upward to 618 +/- 258 micromol/L at 360 minutes. FFA concentrations from 180 to 360 minutes did not differ in the IM-FSIGT versus NS-Study. As the 4 FFA phases did not differ between protocols, the insulin effect on FFA levels in the FSIGT can be attributed to endogenous insulin. But the similarity in FFA levels from 180 to 360 minutes in the IM-FSIGT and NS-Study suggests diurnal variation and not a dynamic related to insulin or the FSIGT protocol is responsible for the final suprabasal FFA plateau.
由于胰岛素浓度的微小增加会深刻影响脂肪分解,我们的目标是描述频繁采样静脉葡萄糖耐量试验(FSIGT)期间的游离脂肪酸(FFA)谱,并确定内源性和外源性胰岛素是否都会影响FFA谱。13名受试者分别进行了仅葡萄糖(GO-FSIGT)和胰岛素改良的FSIGT(IM-FSIGT)。两种方案均持续6小时。在基线时给予静脉葡萄糖推注(0.3 g/kg)。在IM-FSIGT中,胰岛素在20至25分钟内输注(4 mU/kg·min)。另外6名受试者进行了IM-FSIGT和生理盐水研究(NS-研究)。对于NS-研究,输注的是生理盐水而非葡萄糖和胰岛素。所有测试的空腹血糖、胰岛素、FFA和肾上腺素浓度相似。两种FSIGT中内源性胰岛素均在4±1分钟达到峰值。IM-FSIGT中外源性胰岛素的平均计算峰值时间为26±1分钟。与GO-FSIGT相比,IM-FSIGT中的葡萄糖浓度较低,肾上腺素浓度较高。在FSIGT期间,FFA时间进程显示出四个不同阶段,两种方案之间无差异。在第一阶段(0至11分钟),FFA水平保持在接近基础值(491±183 μmol/L);在第二阶段(11至79分钟),FFA水平下降,达到最低点139±63 μmol/L;在第三阶段(79至188分钟),FFA水平呈线性上升并重新达到基础水平;在第四阶段(188至360分钟),FFA水平上升至基础值以上并稳定在732±214 μmol/L(P<.001)。在NS-研究中,FFA水平在180分钟之前保持在接近基线(388±118 mEq/L),然后在360分钟时向上趋势至618±258 μmol/L。IM-FSIGT与NS-研究中180至360分钟的FFA浓度无差异。由于两种方案的4个FFA阶段无差异,FSIGT中胰岛素对FFA水平的影响可归因于内源性胰岛素。但IM-FSIGT和NS-研究中180至360分钟FFA水平的相似性表明,昼夜变化而非与胰岛素或FSIGT方案相关的动态变化是最终超基础FFA平台期的原因。